NCT07138638View on ClinicalTrials.gov

High-Frequency QRS for Predicting Microvascular Dysfunction and Adverse Events After PCI in Acute Myocardial Infarction

Not yet recruitingOBSERVATIONAL

Enrollment

1,112

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

December 31, 2027

Conditions

AMI

Interventions

DEVICE

High-Frequency QRS

All enrolled patients underwent HF-QRS assessment, with subsequent recording of MACE to evaluate the predictive value of HF-QRS parameters for clinical outcomes

Trial Locations (1)

221000

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

All Listed Sponsors

lead

The Affiliated Hospital of Xuzhou Medical University

OTHER

NCT07138638 - High-Frequency QRS for Predicting Microvascular Dysfunction and Adverse Events After PCI in Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter